Summary: Ongoing evaluation of the evidence-based guidelines is required to ensure optimal management of febrile neutropenia. Therefore, it is important that international and national surveys are carried out to maintain databases of susceptibility profiles of common pathogens. This should also be supplemented by ongoing research into the development of new antimicrobial agents effective against resistant pathogens.